The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Infarct Volume Is a Pivotal Biomarker After Intra-Arterial Stroke Therapy
Abstract
Background and Purpose—: Pretreatment infarct volume appears to predict clinical outcome after intra-arterial therapy. To confirm the importance of infarct size in patients undergoing intra-arterial therapy, we sought to characterize the relationship between final infarct volume (FIV) and long-term functional outcome in a prospective cohort of endovascularly treated patients. Methods—: From our prospective intra-arterial therapy database, we identified 107 patients with acute ischemic stroke with anterior circulation proximal artery occlusions who underwent final infarct imaging and had 3-month modified Rankin Scale scores. Clinical, imaging, treatment, and outcome data were analyzed. Results—: Mean age was 66.6 years. Median admission National Institutes of Health Stroke Scale score was 17. Reperfusion (Thrombolysis In Cerebral Infarction 2A–3) was achieved in 78 (72.9%) patients. Twenty-seven (25.2%) patients achieved a 3-month good outcome (modified Rankin Scale 0–2), and 30 (28.0%) died. Median FIV was 71.4 cm 3 . FIV independently correlated with functional outcome across the entire modified Rankin Scale. In receiver operating characteristic analysis, it was the best discriminator of both good outcome (area under the curve=0.857) and mortality (area under the curve=0.772). A FIV of approximately 50 cm 3 demonstrated the greatest accuracy for distinguishing good versus poor outcome, and a FIV of approximately 90 cm 3 was highly specific for a poor outcome. The interaction term between FIV and age was the only independent predictor of good outcome ( P <0.0001). The impact of FIV was accentuated in patients <80 years. Conclusions—: Among patients with anterior circulation acute ischemic stroke who undergo intra-arterial therapy, final infarct volume is a critical determinant of 3-month functional outcome and appears suitable as a surrogate biomarker in proof-of-concept intra-arterial therapy trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Cited by
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Goyal, M., Demchuk, A. M., Menon, B. K., Eesa, M., Rempel, J. L., Thornton, J., Roy, D., Jovin, T. G., Willinsky, R. A., Sapkota, B. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414905 · Cited by 6,083
Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone
Mocco, J., Zaidat, O. O., von Kummer, R., Yoo, A. J., Gupta, R., Lopes, D., Frei, D., Shownkeen, H., Budzik, R., Ajani, Z. A., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013372 · Cited by 296
Self-citationAgarwal, S., Scher, E., Lord, A., Frontera, J., Ishida, K., Torres, J., Rostanski, S., Mistry, E., Mac Grory, B., Cutting, S., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.027476 · Cited by 60
Metadata
- Authors
- Yoo, A. J., Chaudhry, Z. A., Nogueira, R. G., Lev, M. H., Schaefer, P. W., Schwamm, L. H., Hirsch, J. A., & González, R. G.
- Venue
- Stroke
- Published
- 2012-05
- Volume
- 43
- Issue
- 5
- Pages
- 1323-1330
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1996667632
- Cited by
- 223
- References
- 1
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Infarct Volume Is a Pivotal Biomarker After Intra-Arterial Stroke Therapy. https://app.cochat.ai/papers/10.1161/strokeaha.111.639401
- The paper
- Yoo, A. J., Chaudhry, Z. A., Nogueira, R. G., Lev, M. H., Schaefer, P. W., Schwamm, L. H., Hirsch, J. A., & González, R. G. (2012). Infarct Volume Is a Pivotal Biomarker After Intra-Arterial Stroke Therapy. Stroke. https://doi.org/10.1161/strokeaha.111.639401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.